Standardising biochemical assessment of bone turnover in osteoporosis

被引：8

作者：

Vasikaran, Samuel D. ^{[1
,2
]}

Morris, Howard A. ^{[3
]}

Cooper, Cyrus ^{[4
,5
]}

Kanis, John A. ^{[6
]}

机构：

[1] Royal Perth Hosp, Dept Core Clin Pathol & Biochem, PathWest Lab Med, Perth, WA 6001, Australia

[2] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia

[3] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia

[4] Univ Southampton, Southampton Gen Hosp, MRC, Lifecourse Epidemiol Unit, Southampton SO16 6YD, Hants, England

[5] Univ Oxford, Inst Musculoskeletal Sci, NIHR Musculoskeletal Biomed Res Unit, Oxford OX3 7LD, England

[6] Univ Sheffield, Sch Med, Ctr Metab Bone Dis, WHO Collaborating Ctr, Sheffield S10 2RX, S Yorkshire, England

来源：

CLINICAL BIOCHEMISTRY | 2011年 / 44卷 / 13期

关键词：

D O I：

10.1016/j.clinbiochem.2011.07.001

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1033 / 1034

页数：2

共 9 条

[1]

[Anonymous], [No title captured]

[2] Bone turnover markers in the management of postmenopausal osteoporosis [J].

Brown, Jacques P. ;

Albert, Caroline ;

Nassar, Bassam A. ;

Adachi, Jonathan D. ;

Cole, David ;

Davison, K. Shawn ;

Dooley, Kent C. ;

Don-Wauchope, Andrew ;

Douville, Pierre ;

Hanley, David A. ;

Jamal, Sophie A. ;

Josse, Robert ;

Kaiser, Stephanie ;

Krahn, John ;

Krause, Richard ;

Kremer, Richard ;

Lepage, Raymond ;

Letendre, Elaine ;

Morin, Suzanne ;

Ooi, Daylily S. ;

Papaioaonnou, Alexandra ;

Ste-Marie, Louis-Georges .

CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) :929-942

[3] PERSPECTIVE - THE DIAGNOSIS OF OSTEOPOROSIS [J].

KANIS, JA ;

MELTON, LJ ;

CHRISTIANSEN, C ;

JOHNSTON, CC ;

KHALTAEV, N .

JOURNAL OF BONE AND MINERAL RESEARCH, 1994, 9 (08) :1137-1141

[4] A reference standard for the description of osteoporosis [J].

Kanis, John A. ;

McCloskey, Eugene V. ;

Johansson, Helena ;

Oden, Anders ;

Melton, L. Joseph, III ;

Khaltaev, Nikolai .

BONE, 2008, 42 (03) :467-475

[5] Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide [J].

Koivula, Marja-Kaisa ;

Ruotsalainen, Vesa ;

Bjorkman, Mikko ;

Nurmenniemi, Sini ;

Ikaheimo, Risto ;

Savolainen, Kari ;

Sorva, Antti ;

Risteli, Juha .

ANNALS OF CLINICAL BIOCHEMISTRY, 2010, 47 :67-71

[6] Construction of a FRAXA® model for the assessment of fracture probability in Canada and implications for treatment [J].

Leslie, W. D. ;

Lix, L. M. ;

Langsetmo, L. ;

Berger, C. ;

Goltzman, D. ;

Hanley, D. A. ;

Adachi, J. D. ;

Johansson, H. ;

Oden, A. ;

McCloskey, E. ;

Kanis, J. A. .

OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) :817-827

[7] 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary [J].

Papaioannou, Alexandra ;

Morin, Suzanne ;

Cheung, Angela M. ;

Atkinson, Stephanie ;

Brown, Jacques P. ;

Feldman, Sidney ;

Hanley, David A. ;

Hodsman, Anthony ;

Jamal, Sophie A. ;

Kaiser, Stephanie M. ;

Kvern, Brent ;

Siminoski, Kerry ;

Leslie, William D. .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (17) :1864-1873

[8] Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards [J].

Vasikaran, S. ;

Eastell, R. ;

Bruyere, O. ;

Foldes, A. J. ;

Garnero, P. ;

Griesmacher, A. ;

McClung, M. ;

Morris, H. A. ;

Silverman, S. ;

Trenti, T. ;

Wahl, D. A. ;

Cooper, C. ;

Kanis, J. A. .

OSTEOPOROSIS INTERNATIONAL, 2011, 22 (02) :391-420

[9] Economic implications of hip fracture: Health service use, institutional care and cost in Canada [J].

Wiktorowicz, ME ;

Goeree, R ;

Papaioannou, A ;

Adachi, JD ;

Papadimitropoulos, E .

OSTEOPOROSIS INTERNATIONAL, 2001, 12 (04) :271-278

← 1 →